Publications (19) Alfonso Jesús Domínguez-Gil Hurlé publications

filter_list General Pharmacology, Toxicology and Pharmaceutics

2013

  1. Impact of pharmacogenetics on CNS side effects related to efavirenz

    Pharmacogenomics, Vol. 14, Núm. 10, pp. 1167-1178

  2. Pharmacogenetic analysis of SNPs in genes involved in the pharmacokinetics and response to lopinavir/ritonavir therapy

    Current Drug Metabolism, Vol. 14, Núm. 7, pp. 729-737

2011

  1. Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma

    Clinical Biochemistry, Vol. 44, Núm. 2-3, pp. 260-263

2010

  1. Clinical repercussions of analytical interferences due to aldosterone antagonists in digoxin immunoassays: An assessment

    Therapeutic Drug Monitoring, Vol. 32, Núm. 2, pp. 169-176

2008

  1. Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 4, pp. 948-954

2007

  1. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients

    Intensive Care Medicine, Vol. 33, Núm. 2, pp. 279-285

1996

  1. FARMACOCINETICA CLINICA DE LOS INHIBIDORES SELECTIVOS DE LA RECAPTACION DE SEROTONINA

    Farmacia Hospitalaria, Vol. 20, Núm. 2, pp. 73-85

1993

  1. Contribution of biopharmaceutics and pharmacokinetics to improve drug therapy

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 18, Núm. 1, pp. 1-5

1992

  1. EL METAANALISIS COMO TECNICA CUANTITATIVA DE LAS REVISIONES DE LA LITERATURA

    Farmacia Hospitalaria, Vol. 16, Núm. 4, pp. 225-234

  2. LIMITACIONES ANALITICAS EN LA MONITORIZACION DE NIVELES SERICOS DE DIGOXINA

    Farmacia Clinica, Vol. 9, Núm. 9, pp. 774-785

  3. Population pharmacokinetics of imipramine in children

    European Journal of Clinical Pharmacology, Vol. 43, Núm. 1, pp. 89-92

1989

  1. Pharmacokinetic and nephrotoxic study of gentamicin in rabbits using a new dosage regimen

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 14, Núm. 2, pp. 169-175

  2. Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 14, Núm. 1, pp. 19-22

1987

  1. In vitro interaction between HAPA-gentamicin B and penicillins

    International Journal of Pharmaceutics, Vol. 37, Núm. 1-2, pp. 113-117

1983

  1. Pharmacokinetics of cefoxitin during haemofiltration

    European Journal of Clinical Pharmacology, Vol. 25, Núm. 3, pp. 395-398

1981

  1. Influence of the route of administration on the pharmacokinetics of amikacin

    European Journal of Clinical Pharmacology, Vol. 19, Núm. 5, pp. 367-370

1980

  1. Influence of dose on the pharmacokinetics of Cefadroxil

    European Journal of Clinical Pharmacology, Vol. 18, Núm. 6, pp. 505-509

1979

  1. Pharmacokinetics of cefoxitin in patients with normal or impaired renal function

    European Journal of Clinical Pharmacology, Vol. 16, Núm. 2, pp. 119-124

  2. Pharmacokinetics of cephacetrile in patients undergoing haemodialysis

    European Journal of Clinical Pharmacology, Vol. 16, Núm. 1, pp. 49-52